These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19956394)

  • 1. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX.
    Yu Y; Kanwar SS; Patel BB; Nautiyal J; Sarkar FH; Majumdar AP
    Transl Oncol; 2009 Dec; 2(4):321-8. PubMed ID: 19956394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.
    Nautiyal J; Kanwar SS; Yu Y; Majumdar AP
    J Mol Signal; 2011 Jul; 6():7. PubMed ID: 21774804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.
    Patel BB; Gupta D; Elliott AA; Sengupta V; Yu Y; Majumdar AP
    Anticancer Res; 2010 Feb; 30(2):319-25. PubMed ID: 20332435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.
    Kanwar SS; Yu Y; Nautiyal J; Patel BB; Padhye S; Sarkar FH; Majumdar AP
    Pharm Res; 2011 Apr; 28(4):827-38. PubMed ID: 21161336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.
    Patel BB; Sengupta R; Qazi S; Vachhani H; Yu Y; Rishi AK; Majumdar AP
    Int J Cancer; 2008 Jan; 122(2):267-73. PubMed ID: 17918158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
    Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Cinnamic acid and FOLFOX in diminishing side population and downregulating cancer stem cell markers in colon cancer cell line HT-29.
    Soltanian S; Riahirad H; Pabarja A; Jafari E; Khandani BK
    Daru; 2018 Sep; 26(1):19-29. PubMed ID: 30209760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.
    Yu Y; Sarkar FH; Majumdar AP
    Transl Oncol; 2013 Apr; 6(2):180-6. PubMed ID: 23544170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
    Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
    Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: a potential therapeutic agent for recurrent colon cancer.
    Nangia-Makker P; Yu Y; Vasudevan A; Farhana L; Rajendra SG; Levi E; Majumdar AP
    PLoS One; 2014; 9(1):e84369. PubMed ID: 24465408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Chun HK; Lee WY; Park YS
    Med Oncol; 2010 Dec; 27(4):1277-85. PubMed ID: 19949897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of has_circ_0055625 in Colon Cancer Patients Undergoing FOLFOX Chemotherapy Treatment.
    Liu X; Gao L; Shi S; Yang Y
    Int J Gen Med; 2021; 14():221-227. PubMed ID: 33519228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
    Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
    Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.
    Chen D; Li L; Zhang X; Gao G; Shen L; Hu J; Yang M; Liu B; Qian X
    Medicine (Baltimore); 2018 Mar; 97(10):e0097. PubMed ID: 29517682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells.
    Reddy S; Rishi AK; Xu H; Levi E; Sarkar FH; Majumdar AP
    Nutr Cancer; 2006; 55(2):185-94. PubMed ID: 17044774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auraptene and its effects on the re-emergence of colon cancer stem cells.
    Epifano F; Genovese S; Miller R; Majumdar AP
    Phytother Res; 2013 May; 27(5):784-6. PubMed ID: 22761031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy.
    Feng Y; Gao S; Gao Y; Wang X; Chen Z
    Oncotarget; 2016 Dec; 7(49):81402-81409. PubMed ID: 27833077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Chen A; Xu J; Johnson AC
    Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.